In the TME, cancer cells bind to the PD-1 protein found on T lymphocytes through the PD-L1 ligand, making it impossible for T-cells recognize tumors and enabling cancer cells to evade immune system attacks [45]. The gene discussed is PDCD1; the disease is cancer.